In a distinct study, Vaishnavi et al. [39] specifically investigated the signaling requirement for EGFR in a panel of lung cancer cell lines driven by oncogenic fusion kinases including ALK, but also ROS1, NTRK1 and RET. The gene discussed is ALK; the disease is lung cancer.